Importance of Residual Myocardial Ischemia After Intervention in the Genesis of Cardiovascular Events Among Patients with Chronic Coronary Artery Disease-Reference-Cited by-同舟云学术

Importance of Residual Myocardial Ischemia After Intervention in the Genesis of Cardiovascular Events Among Patients with Chronic Coronary Artery Disease

Published:2011-06-09 Issue:4 Volume:13 Page:280-286
ISSN:1523-3782
Container-title:Current Cardiology Reports
language:en
Short-container-title:Curr Cardiol Rep

Author:

Shaw Leslee J.,Hachamovitch Rory,Min James,Berman Daniel S.

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s11886-011-0193-2.pdf

Reference29 articles.

1. Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. Optimal medical therapy with or without pci for stable coronary disease. N Engl J Med. 2007;356:1503–16.

2. Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF, MacGregor JM, et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med. 2009;360:2503–15.

3. • Shaw LJ, Berman DS, Maron DJ, Mancini GB, Hayes SW, Hartigan PM, Weintraub WS, O’Rourke RA, Dada M, Spertus JA, Chaitman BR, Friedman J, Slomka P, Heller GV, Germano G, Gosselin G, Berger P, Kostuk WJ, Schwartz RG, Knudtson M, Veledar E, Bates ER, McCallister B, Teo KK, Boden WE. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: Results from the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial nuclear substudy. Circulation. 2008;117:1283–1291. This paper reports the results from the COURAGE nuclear substudy in 314 patients who underwent serial testing for the purposes of defining the efficacy of randomized treatments for reducing ischemia. The results of this substudy reveal an advantage with PCI plus optimal medical therapy in terms of ischemia reduction when compared with optimal medical therapy alone.

4. Shaw LJ, Iskandrian AE. Prognostic value of gated myocardial perfusion spect. J Nucl Cardiol. 2004;11:171–85.

5. Berman DS, Hachamovitch R, Kiat H, Cohen I, Cabico JA, Wang FP, et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: A basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol. 1995;26:639–47.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognosis in the era of comparative effectiveness research: Where is nuclear cardiology now and where should it be?;Journal of Nuclear Cardiology;2012-07-04